Sharemaestro Newsreel

Evercore Maintains Enovis Corp(ENOV.US) With Buy Rating, Maintains Target Price $32

Evercore has reiterated its Buy rating on Enovis Corp (ENOV.US) and maintained its target price at $32. This indicates a continued positive outlook from the firm regarding the company's stock performance.

Earnings Release: Here's Why Analysts Cut Their Pacific Biosciences of California, Inc. (NASDAQ:PACB) Price Target To US$2.29

Analysts have lowered their price target for Pacific Biosciences of California (NASDAQ:PACB) to US$2.29 after the company's recent earnings report, which saw revenue fall short of estimates and increased projected losses per share for 2026. The revised forecasts indicate a slowdown in revenue growth …

12% Undervalued? GE HealthCare Technologies (GEHC) After New Ultrasound Launches

GE HealthCare Technologies (GEHC) is back in focus after launching new ultrasound systems that were

Insider trades: Microsoft, Meta, Pfizer among notable names

[Meta European head office] Derick Hudson Insider transactions were seen across major firms this week, including Microsoft (MSFT [https://seekingalpha.com/symbol/MSFT]) and Meta (META [https://seekingalpha.com/symbol/META]). The following trades took place between August 3 and August 7. * Microsoft (MSFT [https://seekingalpha.com/symbol/MSFT]) saw two executives divest a small …

AdaptHealth (AHCO) Reports A Net Loss And Goodwill Impairment, Is The Stock A Bargain?

Wall Street Zen Upgrades RxSight (NASDAQ:RXST) to Hold

Wall Street Zen has upgraded RxSight (NASDAQ:RXST) from a "sell" to a "hold" rating, while the broader analyst consensus remains "Reduce" with an $8.59 average price target. This upgrade follows RxSight reporting better-than-expected quarterly results, with a loss of $0.29 per share against an …

Brainsway Ltd (BWAY) Stock News Today

This page on TradingKey provides current stock news for Brainsway Ltd (BWAY), a company in the Healthcare Equipment & Supplies sector. As of the closing bell on August 7th, BWAY was trading at $15.500, down 0.96%. The page indicates that more news will be …

Inogen (INGN) Has a New Rating from B. Riley Securities

B. Riley Securities initiated coverage on Inogen (INGN) with a Buy rating and a $14.00 price target, following Needham's Buy rating and $12.00 price target for the stock. Inogen reported a quarterly revenue of $95.08 million and a GAAP net loss of $3.85 million …

Insulet Corporation (NASDAQ:PODD) Just Reported, And Analysts Assigned A US$172 Price Target

Insulet Corporation's stock dropped 15% to US$141 despite reporting revenues in line with expectations and slightly better-than-expected statutory profits of US$1.37 per share. Analysts maintained their 2026 revenue and EPS forecasts at US$3.29 billion and US$6.17, respectively, but cut the consensus price target by …

Earnings Preview: Beyond Air to Report Financial Results on August 13

Beyond Air (NASDAQ: XAIR) is scheduled to announce its financial results on August 13. Analysts are forecasting an EPS of -$0.17 for the quarter, with revenue estimates ranging from $1.39 million to $1.6 million.

TransMedics Group (TMDX) Could Be 41% Undervalued As Earnings And Guidance Land

Insider Buyers At InspireMD Recover Some Losses, But Still Down US$161k

Insiders at InspireMD bought US$420.8k worth of stock over the last year, but despite a recent 14% stock gain, they are still down US$161k on their purchases. While there was some insider selling, the net insider activity over the year indicates more buying than …

Treace Medical Concepts, Inc. (TMCI) Stock Price, News, Quote & History

This page provides a comprehensive overview of Treace Medical Concepts, Inc. (TMCI) stock, including its current price, after-hours trading, historical data, and key financial metrics. It also features company news, analyst ratings, and a detailed description of its medical devices and technologies, such as …

Varex Imaging Corp (VREX) Stock News Today

This article provides current stock information for Varex Imaging Corp (VREX), including its latest stock price, market capitalization, and a note indicating that more news is coming soon. The stock closed at $12.410, up 1.31%, with a market cap of $523.04 million. It also …

DexCom, Inc. $DXCM Stock Position Lifted by Gradient Investments LLC

Gradient Investments LLC increased its stake in DexCom, Inc. (NASDAQ:DXCM) by 16.7% in the second quarter, bringing its total holdings to 372,542 shares valued at approximately $25.1 million. DexCom recently reported strong quarterly earnings, beating expectations with $0.70 EPS and a 13.1% year-over-year revenue …

Sera Prognostics Q1 2026 Earnings: In-Line Loss of -$0.17 Per Share as Shares Advance 3.5% - EBITDA Analysis

Is Neogen (NEOG) Still Undervalued After Flat Earnings And New Guidance?

Insider Selling: 908 Devices (NASDAQ:MASS) Director Sells $169,800.00 in Stock

908 Devices (NASDAQ:MASS) Director Christopher Brown sold 20,000 shares of the company's stock on August 5th for $169,800. This transaction, executed under a pre-arranged Rule 10b5-1 trading plan, reduced his ownership by 2.37% to 823,359 shares. The stock is currently trading at $8.88, near …

The Robotic Surgery Leader: Intuitive Surgical Slides Further But One Wall Street Bull Pegs Returns at 85%

Quick Read ISRG dropped 34% on a slower procedure growth guide, yet Q2 EPS of $2.80 crushed the $2.50 consensus for a fifth straight quarterly beat. ISRG trades 28% below Wall Street consensus while peers MDT and SYK fell less than 10% YTD, suggesting …

Haemonetics Q1 Earnings Call Highlights

Key Points Interested in Haemonetics Corporation? Here are five stocks we like better. Haemonetics raised its fiscal 2027 outlook, now expecting reported revenue growth of 5%–8% and organic growth of 4%–7%, after first-quarter revenue increased 6% to $339 million and adjusted EPS rose 4% …

SINTX Technologies Inc (SINT) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for SINTX Technologies Inc (SINT), indicating a current earnings forecast score of 8.00 and an average price target of $16.00 based on three analysts. It details expected revenue for the next quarter, historical EPS performance, and an analyst …

Cytek Biosciences, Inc. (8EQ.MU) Analyst Insights, Price Targets & Recommendations

This article provides analyst insights, price targets, and recommendations for Cytek Biosciences, Inc. (8EQ.MU). It lists several recent analyst actions including upgrades, downgrades, and maintained ratings from firms like Piper Sandler, Goldman Sachs, Stephens & Co., and Morgan Stanley, along with the corresponding dates. …

Medtronic PLC $MDT Shares Purchased by Gradient Investments LLC

Gradient Investments LLC increased its stake in Medtronic PLC (NYSE:MDT) by 3.9% during the second quarter, bringing its total holdings to 496,513 shares valued at approximately $38.8 million. Other institutional investors also adjusted their positions in the medical technology company, with 82.06% of the …

iRadimed (NASDAQ:IRMD) Cut to "Hold" at Wall Street Zen

iRadimed (NASDAQ:IRMD) has been downgraded to a "Hold" rating by Wall Street Zen and Weiss Ratings, despite analysts maintaining a "Moderate Buy" consensus with an average price target of $120. The company recently surpassed quarterly earnings and revenue expectations. CEO Roger E. Susi sold …

IceCure Medical Shareholders Approve Special Meeting Agenda on August 6, 2026

IceCure Medical shareholders approved the sole agenda item at a Special General Meeting held on August 6, 2026, in Caesarea, Israel, after the meeting was reconvened due to a lack of quorum. The company has filed a Form 6-K with the U.S. SEC to …

Globus Medical Q2 Earnings Call Highlights

Key Points Interested in Globus Medical, Inc.? Here are five stocks we like better. Q2 revenue rose 6% to $789.6 million, while record non-GAAP EPS increased 56% to $1.34 and adjusted EBITDA margin expanded to 35.4%. Spine and trauma growth offset declines in enabling …

Pacer Advisors Inc. Has $2.72 Million Holdings in GE HealthCare Technologies Inc. $GEHC

Pacer Advisors Inc. reduced its stake in GE HealthCare Technologies Inc. by 44.8% in the first quarter, now holding 38,183 shares valued at $2.72 million. Despite this, GE HealthCare reported strong quarterly earnings, beating analyst estimates with $1.13 EPS and a 5.8% increase in …

Earnings call transcript: Sanuwave Health misses Q2 2026 estimates as sales slide

Sanuwave Health reported a wider-than-expected loss and missed revenue estimates for Q2 2026, primarily due to a sharp decline in UltraMIST system sales, despite growth in recurring applicator revenue. The company withdrew its full-year 2026 revenue guidance, citing uncertainty surrounding potential Medicare reimbursement changes …

SANUWAVE Health, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:SNWV) 2026-08-07

This article provides details on SANUWAVE Health, Inc.'s Q2 2026 earnings call presentation. The company published a slide deck in conjunction with the call, which is the subject of this content. The article was written by SA Transcripts, a team responsible for publishing numerous …

Royal Bank of Canada Decreases Stake in UFP Technologies, Inc. $UFPT

Royal Bank of Canada reduced its stake in UFP Technologies (NASDAQ:UFPT) by 12.5% in the first quarter, selling 11,343 shares and retaining 79,179 shares valued at $15.3 million. Despite this, UFP Technologies reported strong quarterly earnings of $2.92 EPS and revenue of $173.96 million, …

Janus Henderson Group PLC Has $3.76 Million Stock Holdings in UFP Technologies, Inc. $UFPT

Janus Henderson Group PLC significantly reduced its stake in UFP Technologies, Inc. (NASDAQ:UFPT) by 75.5% in the first quarter, now holding 19,436 shares valued at $3.76 million. Despite this, other institutional investors have increased their holdings, with institutional investors collectively owning 87.28% of the …

MaxCyte (MXCT) Q1 2026 Earnings: Narrower Loss Beats Estimates as Shares Rise 6.31% - Revenue Estimate Trend

DexCom, Inc. $DXCM Shares Sold by Pacer Advisors Inc.

Pacer Advisors Inc. significantly reduced its stake in DexCom (NASDAQ:DXCM) by 96.5% in the first quarter, selling 948,754 shares and retaining 34,025 shares. Despite this, institutional investors and hedge funds still own 97.75% of the company, and analyst sentiment remains positive with a "Moderate …

Integra LifeSciences Holdings Corporation (IART) Interactive Stock Chart

PAVM Q2'26 Earnings: revenue estimate is 48.00K USD

PAVmed Inc. (PAVM) is scheduled to release its Q2'26 earnings on August 14th, with an expected revenue estimate of $48.00 thousand USD and an anticipated EPS of ($0.47). The article also provides a table comparing reported and estimated revenues and EPS from Q2'25 through …

Novocure Ltd (NVCR) Stock Analysis & Forecast

Novocure Ltd (NVCR) saw its stock surge to $19.91 following stronger-than-expected Q2 2026 earnings. The company reported revenue that exceeded consensus estimates, growing 8.6% year-over-year. This recovery is primarily attributed to the FDA approval and multi-indication expansion of its Optune Pax treatment, especially after …